Clinical Trials Logo

Mild Cognitive Impairment clinical trials

View clinical trials related to Mild Cognitive Impairment.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06389812 Active, not recruiting - Dementia Clinical Trials

Dual-task Exercise in People With Cognitive Impairment

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to explore how performing two exercise-based tasks simultaneously (dual-task exercise) affects the neurovascular and cognitive responses of people with cognitive impairment, which is a growing concern globally. Specifically, the study will examine how motor-cognitive dual-task exercises, such as using elastic resistance bands combined with visual perception training, including eye movement exercises, can immediately improve outcomes such as Brain-derived neurotrophic factor (BDNF) levels, cerebral blood flow, cognitive function, and mobility. BDNF is a special chemical in our brain that helps with the connections between brain cells. Participants will be asked to complete a single 30-minute exercise session and undergo assessments before and after the intervention. Participants with cognitive impairment will be initially assessed using Mini-Mental State Examination (MMSE) which is a 30-point questionnaire used extensively in clinical and research settings to measure cognitive impairment. Any score of 24 or more (out of 30) indicates normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points), or mild (19-23 points) cognitive impairment. Participants with lower MMSE scores (<10) will be removed from the study.

NCT ID: NCT06372002 Active, not recruiting - Dementia Clinical Trials

Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia

Start date: October 16, 2023
Phase: N/A
Study type: Interventional

This study aims to evaluate the effectiveness and cost-effectiveness of CST-ES, the Spanish adaptation of Cognitive Stimulation Therapy (CST), to improve cognition and quality of life in people with mild to moderate dementia. The evaluation will be conducted as a pragmatic multicenter randomized controlled clinical trial. Participants will be randomized to receive 7 weeks of CST-ES followed by 24 weeks of maintenance CST-ES (intervention group) or to continue their usual treatment (control group).

NCT ID: NCT06297044 Active, not recruiting - Healthy Clinical Trials

Neural and Cognitive Correlates of Pragmatic Abilities

APACS_Neuro
Start date: March 29, 2018
Phase:
Study type: Observational

Pragmatics of language refers to the set of abilities that allow one to use and interpret language according to context and, in general, to communicate effectively. Disorders in the pragmatics of language are prevalent in various clinical populations. They are a cause of social withdrawal and worse quality of life, both for patients directly affected and for their family members. Despite this, this type of disorder is rarely considered in neuropsychological assessment and rehabilitation. This study's objective is to characterize pragmatic deficits in various neurological populations, allowing for the most accurate diagnosis possible and leading to the planning of personalized and effective Rehabilitation Plans.

NCT ID: NCT06083350 Active, not recruiting - Alzheimer Disease Clinical Trials

Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment

Start date: June 27, 2023
Phase: N/A
Study type: Interventional

Patients with mild cognitive impairment aged 50-80 years old were recruited in Shiyan City, Hubei Province, and divided into intervention group and placebo group. They were given yeast β-glucan capsules and starch capsules, respectively, for 6 months, in order to explore whether yeast β-glucan can improve cognitive function of patients with mild cognitive impairment by regulating gut microbiota and its metabolites.

NCT ID: NCT05938426 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Digital Therapeutics Research on Efficiency About Mild Cognitive Impairment Study

DREAM
Start date: June 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficiency and safety of a digital therapeutics(ET-101) for mild cognitive impairment (MCI). This is a randomized, sham-controlled, assessor-blinded, 24-week parallel study. 100 MCI patients will be randomly assigned to two groups. The control group will be provided with a sham device.

NCT ID: NCT05818423 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Brain Health Together: A Live-Streaming Group-Based Digital Program

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and test a comprehensive Brain Health Together program for older adults living with cognitive decline.

NCT ID: NCT05785871 Active, not recruiting - Hypertension Clinical Trials

Hypertension, Brain Clearance, and Markers of Neurodegeneration

Start date: November 18, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this research study is to measure cerebrospinal fluid (CSF) clearance in subjects with and without high blood pressure. CSF cushions the brain from impact and carries waste products from the brain to the bloodstream. This process is known as clearance. Impaired removal of proteins from the aging brain causes their buildup and may contribute to an increased risk for Alzheimer's disease. It is also suspected that clearance may be related to the health of vessels carrying the blood throughout the brain. It is known that high blood pressure damages blood vessels and thus may impair clearance. In this project we will examine if having high blood pressure is related to impaired brain clearance and whether treating high blood pressure improves clearance and reduces buildup of Alzheimer's disease-related proteins. Participants will be asked to undergo a medical examination, testing of memory, brain imaging (both magnetic resonance and positron emission tomography, and spinal tap at the beginning of the study and 1 -2 years later.

NCT ID: NCT05768425 Active, not recruiting - Alzheimer Disease Clinical Trials

DIagnostic Biomarkers and Symptoms in Patients With Alzheimer's Disease and Lewy bodY Dementia

DISPLAY
Start date: February 1, 2023
Phase:
Study type: Observational

This a study to improve diagnosis of dementia with Lewy bodies with RT-QuIC in different biospecimens.

NCT ID: NCT05735041 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Computerized Cognitive Training in Patients With Coronary Heart Disease and Mild Cognitive Impairment

COG-T CHD
Start date: January 18, 2023
Phase: N/A
Study type: Interventional

In this study, a multicentre, double-blind, randomized controlled study based on cognitive training was conducted in patients with coronary heart disease and cognitive impairment but without dementia, to evaluate the effectiveness of computer-based digital therapy in improving the cognitive function of such patients.

NCT ID: NCT05634161 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Usability of Cognitive Improvement Software in Cognitively Impaired Patients: Pilot Study

Start date: November 21, 2022
Phase:
Study type: Observational

Usability study of software application that provide digitized cognitive intervention therapy for cognitively impaired patients.